Optimizing ribavirin exposure by therapeutic drug monitoring improves treatment response in patients with chronic hepatitis C genotype 1
Stickel F, Worni M, Pache I, Moradpour D, Helbling B, Borovicka J, Gerlach T. Optimizing ribavirin exposure by therapeutic drug monitoring improves treatment response in patients with chronic hepatitis C genotype 1. Am J Gastroenterol 2013; 108:1176-8.
01.07.2013
Optimizing ribavirin exposure by therapeutic drug monitoring improves treatment response in patients with chronic hepatitis C genotype 1
01.07.2013
Am J Gastroenterol 2013; 108:1176-8
Stickel Felix, Worni Mathias, Pache Isabelle, Moradpour Darius, Helbling Beat, Borovicka Jan, Gerlach Tilman J
Weiter
